Biocon Limited General Overview Biocon Is An Indian Biopharmaceutical Biocon company focused on manufacturing and exporting papain, a plant enzyme, and isinglass, a marine hydrocolloid, which is essential for the brewing industry. Biocon limited is an indian biopharmaceutical company based in bengaluru, with u.s. headquarters in bridgewater, new jersey. the company was founded by kiran mazumdar shaw in 1978. [4].
Biocon India S Largest Biopharmaceutical Company Access our latest biocon annual report 2023 relentless pursuit. differentiated growth. Kiran mazumdar shaw, one of india's richest self made women, founded biopharmaceutical firm biocon, in 1978. the firm has successfully forayed into the lucrative u.s. market, and it also has one. Established in 1978, biocon has grown from a small garage based operation into a global biopharma giant valued at approximately ₹30,000 crore ($3.6 billion usd). Known as an international pioneer, biocon limited, is an indian biopharmaceutical firm founded by kiran mazumdar shaw in 1978. the company is based in bangalore, india, and produces generic active pharmaceutical ingredients (apis) that are distributed in over 120 countries worldwide.
Biocon S History Founding Day Milestones Product Launches Established in 1978, biocon has grown from a small garage based operation into a global biopharma giant valued at approximately ₹30,000 crore ($3.6 billion usd). Known as an international pioneer, biocon limited, is an indian biopharmaceutical firm founded by kiran mazumdar shaw in 1978. the company is based in bangalore, india, and produces generic active pharmaceutical ingredients (apis) that are distributed in over 120 countries worldwide. Having come from a middle class family and becoming a billionaire, kiran mazumdar shaw, the founder of biocon limited, is undoubtedly one of the country’s most successful business tycoons. Biocon limited's integrated annual report for fy 2024 highlights the company's commitment to maximizing value through a synergistic approach across its diverse business verticals, including generics, biosimilars, research services, and novel biologics. In 1978, kiran mazumdar shaw embarked on a remarkable entrepreneurial journey with just 10,000 rs and a vision to establish a biotechnology company. today, that company is known as biocon limited, a global leader in the field of biopharmaceuticals, with a market value exceeding 50,000 crores. The company is in the business of manufacturing active pharmaceutical ingredients (apis) and formulations, including biosimilar drugs for diabetics, oncology and autoimmune diseases.
Biocon S History Founding Day Milestones Product Launches Having come from a middle class family and becoming a billionaire, kiran mazumdar shaw, the founder of biocon limited, is undoubtedly one of the country’s most successful business tycoons. Biocon limited's integrated annual report for fy 2024 highlights the company's commitment to maximizing value through a synergistic approach across its diverse business verticals, including generics, biosimilars, research services, and novel biologics. In 1978, kiran mazumdar shaw embarked on a remarkable entrepreneurial journey with just 10,000 rs and a vision to establish a biotechnology company. today, that company is known as biocon limited, a global leader in the field of biopharmaceuticals, with a market value exceeding 50,000 crores. The company is in the business of manufacturing active pharmaceutical ingredients (apis) and formulations, including biosimilar drugs for diabetics, oncology and autoimmune diseases.
Biocon Company Profile Revenue Number Of Employees Funding News In 1978, kiran mazumdar shaw embarked on a remarkable entrepreneurial journey with just 10,000 rs and a vision to establish a biotechnology company. today, that company is known as biocon limited, a global leader in the field of biopharmaceuticals, with a market value exceeding 50,000 crores. The company is in the business of manufacturing active pharmaceutical ingredients (apis) and formulations, including biosimilar drugs for diabetics, oncology and autoimmune diseases.
Comments are closed.